Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Adial Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q1 2023
- Shares held
- 2.34M
- −168.4K (−6.7%) vs. Q1 2023
- Total value
- $488.2K
- −$388.7K (−44.3%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Benjamin F. Edwards & Company, Inc. | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 964 | $0 | 0.00% | +964 | New |
| Wells Fargo & Company | 187 | $39 | 0.00% | −732−79.7% | Reduced |
| Morgan Stanley | 535 | $111 | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $2.08K | 0.00% | +10,000 | New |
| Envestnet Asset Management Inc | 13,088 | $2.73K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,623 | $3.67K | 0.00% | −84−0.5% | Reduced |
| Two Sigma Securities, LLC | 20,691 | $4.31K | 0.00% | −28,057−57.6% | Reduced |
| Advisor Group Holdings, Inc. | 24,046 | $5.00K | 0.00% | +700+3.0% | Added |
| Virtu Financial LLC | 26,473 | $6.00K | 0.00% | −19,521−42.4% | Reduced |
| Northern Trust Corp | 29,705 | $6.18K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 33,862 | $7.05K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 36,461 | $8.00K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 52,354 | $10.9K | 0.00% | 00.0% | Unchanged |
| Raffa Wealth Management, LLC | 52,334 | $10.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 107,100 | $22.0K | 0.00% | +6,200+6.1% | Added |
| Geode Capital Management, LLC | 137,464 | $28.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 180,285 | $37.5K | 0.00% | −41,998−18.9% | Reduced |
| BlackRock Inc. | 194,364 | $40.5K | 0.00% | −31,491−13.9% | Reduced |
| Vanguard Group Inc | 203,358 | $42.3K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 1,202,452 | $250.4K | 0.03% | 00.0% | Unchanged |
| Brown Advisory Inc | 0 | $0 | 0.00% | −26,040−100.0% | Sold out |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −10,630−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,748−100.0% | Sold out |